275 related articles for article (PubMed ID: 19727766)
21. Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.
Barczyk M; Schmidt M; Mattoli S
Stem Cell Rev Rep; 2015 Aug; 11(4):598-620. PubMed ID: 25896401
[TBL] [Abstract][Full Text] [Related]
22. Amniotic fluid cells: current progress and emerging challenges in renal regeneration.
Da Sacco S; Perin L; Sedrakyan S
Pediatr Nephrol; 2018 Jun; 33(6):935-945. PubMed ID: 28620747
[TBL] [Abstract][Full Text] [Related]
23. Infusion of Porcine-Derived Amniotic Fluid Stem Cells for Treatment of Experimental Colitis in Mice.
Lin KY; Peng SY; Chou CJ; Lee HS; Lin LC; Pan RY; Wu SC
Chin J Physiol; 2017 Dec; 60(6):345-352. PubMed ID: 29241308
[TBL] [Abstract][Full Text] [Related]
24. Stem cells in cardiovascular regeneration: from preservation of endogenous repair to future cardiovascular therapies.
Templin C; Kränkel N; Lüscher TF; Landmesser U
Curr Pharm Des; 2011 Oct; 17(30):3280-94. PubMed ID: 21919874
[TBL] [Abstract][Full Text] [Related]
25. Clinical potentials of human pluripotent stem cells.
Mora C; Serzanti M; Consiglio A; Memo M; Dell'Era P
Cell Biol Toxicol; 2017 Aug; 33(4):351-360. PubMed ID: 28176010
[TBL] [Abstract][Full Text] [Related]
26. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
[TBL] [Abstract][Full Text] [Related]
27. Stem cell biology and cell transplantation therapy in the retina.
Osakada F; Hirami Y; Takahashi M
Biotechnol Genet Eng Rev; 2010; 26():297-334. PubMed ID: 21415886
[TBL] [Abstract][Full Text] [Related]
28. Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy.
Antonucci I; Pantalone A; Tete S; Salini V; Borlongan CV; Hess D; Stuppia L
Curr Pharm Des; 2012; 18(13):1846-63. PubMed ID: 22352751
[TBL] [Abstract][Full Text] [Related]
29. Stem cell therapy for retinal diseases: update.
Siqueira RC
Stem Cell Res Ther; 2011 Dec; 2(6):50. PubMed ID: 22206617
[TBL] [Abstract][Full Text] [Related]
30. Clinical applications of musculoskeletal tissue engineering.
Roberts SJ; Howard D; Buttery LD; Shakesheff KM
Br Med Bull; 2008; 86():7-22. PubMed ID: 18424445
[TBL] [Abstract][Full Text] [Related]
31. Human mesenchymal stem cells derived from induced pluripotent stem cells down-regulate NK-cell cytolytic machinery.
Giuliani M; Oudrhiri N; Noman ZM; Vernochet A; Chouaib S; Azzarone B; Durrbach A; Bennaceur-Griscelli A
Blood; 2011 Sep; 118(12):3254-62. PubMed ID: 21803852
[TBL] [Abstract][Full Text] [Related]
32. [Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].
Nakamura M; Toyama Y; Okano H
Rinsho Shinkeigaku; 2013; 53(11):1013-5. PubMed ID: 24291863
[TBL] [Abstract][Full Text] [Related]
33. Stem cells and their derivatives: a renaissance in cardiovascular translational research.
Kattman SJ; Koonce CH; Swanson BJ; Anson BD
J Cardiovasc Transl Res; 2011 Feb; 4(1):66-72. PubMed ID: 21061105
[TBL] [Abstract][Full Text] [Related]
34. Human stem cell research and regenerative medicine--present and future.
Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
[TBL] [Abstract][Full Text] [Related]
35. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
Chen W; Huang Q; Ma S; Li M
ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
[TBL] [Abstract][Full Text] [Related]
36. Human amniotic fluid stem cells have better potential in early second trimester of pregnancy and can be reprogramed to iPS.
Shaw SWS; Cheng PJ; Chang YL; Chao AS; Wang TH; Chang SD; Hsieh TT; Chang KH
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):770-774. PubMed ID: 29241918
[TBL] [Abstract][Full Text] [Related]
37. Current Status and Future Prospects of Perinatal Stem Cells.
Torre P; Flores AI
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374593
[TBL] [Abstract][Full Text] [Related]
38. Stem Cell-Based RPE Therapy for Retinal Diseases: Engineering 3D Tissues Amenable for Regenerative Medicine.
Ben M'Barek K; Habeler W; Monville C
Adv Exp Med Biol; 2018; 1074():625-632. PubMed ID: 29721996
[TBL] [Abstract][Full Text] [Related]
39. Pluripotent Stem Cells as a Robust Source of Mesenchymal Stem Cells.
Luzzani CD; Miriuka SG
Stem Cell Rev Rep; 2017 Feb; 13(1):68-78. PubMed ID: 27815690
[TBL] [Abstract][Full Text] [Related]
40. Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.
Féraud O; Valogne Y; Melkus MW; Zhang Y; Oudrhiri N; Haddad R; Daury A; Rocher C; Larbi A; Duquesnoy P; Divers D; Gobbo E; Brunet de la Grange P; Louache F; Bennaceur-Griscelli A; Mitjavila-Garcia MT
PLoS One; 2016; 11(3):e0149291. PubMed ID: 26938212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
